Pasar al contenido principal

NUEVAS HERRAMIENTAS BIO(NANO)TECNOLOGICAS Y BIOFISICAS PARA DECODIFICAR Y REGENERAR EL HUB DEL SISTEMA SURFACTANTE PULMONAR HACIA NUEVAS TERAPIAS RESPIRATORIAS (PULMODECODE)

PID2024-156556OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para la Investigación y el Desarrollo Experimental
Subprograma Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Escaping from Flatland: the role of proteins SP-B and SP-C in the formation of 3D structures in interfacial pulmonary surfactant films

  • Collada Marugán, Ainhoa
  • Carrascosa Tejedor, Javier
  • Sánchez Puga, Pablo
  • Liguori, Alessio
  • Gutfreund, Philipp
  • Santamaría, Andreas
  • Castillo Sánchez, José Carlos
  • Maestro, Armando
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
Deciphering the molecular structure of pulmonary surfactant (PS) at the respiratory air-liquid interface has remained a major challenge since its discovery. This is particularly critical at minimal lung volume and surface area at the end of exhalation, when PS rapidly reorganizes into a 3D membrane network without detaching from the interfacial film, ensuring readiness and stability for subsequent respiratory cycles. Using neutron reflectometry and epifluorescence microscopy in specially designed surface balances, we have investigated the structure of model PS membranes and films at different compression stages, focusing on the key roles of the hydrophobic surfactant proteins SP-B and SP-C in the organization of the system at the interface. The structure of the studied model surfactant films (both analysed orthogonal to the interfacial plane and laterally) strongly depended on composition. We clarified the distinct roles of SP-B and SP-C, revealing that only SP-B, the only protein in surfactant that is indispensable for life, nucleates 3D membrane reservoirs beneath the interface. These findings provide mechanistic insights into how PS maintains interfacial stability during respiration, with potential implications for understanding surfactant dysfunction in respiratory diseases and for designing biomimetic surfactant replacements.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pulmonary surfactant nanoparticles for lung‐targeted and dose‐efficient delivery

  • Fernández Méndez, Laura
  • Piñol Cancer, Marina
  • Souto Riobó, Itziar
  • Urkola Arsuaga, Ainhize
  • González Lozano, Elena
  • Fernández Folgueral, Irene
  • de Alejo, Claudia Miranda Pérez
  • Azkargorta, Mikel
  • Elortza, Felix
  • Tagliaferro Quiñonero, Alberto
  • Silvio, Desire Di
  • Cañadas Benito, Olga
  • Maiz, Jon
  • Pérez Gil, Jesús
  • Ramos Cabrer, Pedro
  • Ruíz Cabello, Jesús
  • Carregal Romero, Susana
Although pulmonary drug delivery enables lung-targeted therapy, its clinical efficacy is often limited by inflammation, heterogeneous deposition, and physiological barriers such as mucociliary clearance and phagocytic uptake. Here, we report a biomimetic platform based on pulmonary surfactant nanoparticles (PSNPs) that preserves native surfactant proteins and biophysical functionality, resulting in enhanced pulmonary delivery. Microfluidic synthesis yielded highly uniform PSNPs with improved encapsulation efficiency and colloidal stability, while markedly increasing surfactant protein retention from 33% using conventional extrusion to 95% via microfluidics, corresponding to a 2.4-fold improvement. Functionally, PSNPs exhibited superior interfacial activity compared to lipid-only liposomes, increasing surface pressure from 5–10 mN/m to 25–30 mN/m, and achieved an approximately 80-fold enhancement in alveolar cellular uptake. In vitro, nintedanib-loaded PSNPs significantly reduced fibroblast migration, proliferation, collagen deposition, and TGF-β secretion relative to free drug and control formulations. In vivo, PSNPs demonstrated high pulmonary retention (95% injected dose per gram of lung tissue), efficient penetration into fibrotic regions, and minimal off-target accumulation in the liver (0.5%). Therapeutic efficacy was confirmed in a bleomycin-induced pulmonary fibrosis model, where PSNPs improved lung function and restored tissue architecture at doses as low as 0.5 mg/kg. Collectively, these results establish PSNPs as a robust lung-targeted nanotherapeutic platform, where microfluidic synthesis enables enhanced biomimicry, improved protein preservation, and superior therapeutic performance compared to conventional fabrication methods.
Docta Complutense
Publicación Artículo científico (JournalArticle)

The lung (surfing) dealer: pulmonary surfactant and drug delivery

  • Cañadas Benito, Olga
  • Hidalgo, Alberto
  • Pérez Gil, Jesús
Introduction The pulmonary route is an attractive route for drug delivery due to its large surface area, extensive vascularization, and avoidance of hepatic first-pass metabolism. Nevertheless, reaching alveolar regions typically requires a complex balance of aerodynamic particle size, airway geometry, patient cooperation and ventilatory capacity. Areas covered Research during two decades has pursued the potential use of pulmonary surfactant, the lipid-protein complex that lines and stabilizes the respiratory air–liquid interface, as drug delivery agent. Lung surfactant may incorporate and solubilize hydrophobic drugs, which could then be delivered into the airways as part of surfactant-based liposomes or nanoparticles. In this review, we summarize recent advances as they have reframed the air–lung lining fluid interface to open the innovative concept of interfacial delivery: drugs could actively spread over the respiratory surface, driven by interfacial forces such as those defining pulmonary surfactant action. Literature included in this review was systematically searched in PubMed, Scopus and Google Scholar using targeted keyword combinations. Expert opinion Key knowledge gaps and technological challenges are identified whose investigation will contribute to develop the full potential of PS-based inhalation delivery strategies.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Disruption of pulmonary surfactant function under oxidative stress: structural and biophysical insights

  • Cejas, Jimena del P.
  • Cañadas Benito, Olga
  • Ledesma, A.
  • Rosa, A.S.
  • Collada Marugán, Ainhoa
  • Blanco Rivero, Amaya
  • Pérez Gil, Jesús
  • Disalvo, E.A.
  • Frías, María de los A.
Pulmonary surfactant forms surface-active films at the air-liquid interface which are essential for alveolar stability but are highly susceptible to oxidative damage under inflammatory conditions. The reactive species hypochlorous acid (HClO/ClO−), generated by activated neutrophils, is a potent oxidant that may compromise surfactant integrity; however, its molecular and functional impact remains incompletely understood. In this study, the effects of oxidative stress induced by HClO/ClO− on the biophysical and structural properties of a fully native porcine surfactant were investigated using Langmuir balance, captive bubble surfactometry, differential scanning calorimetry, FTIR-ATR spectroscopy, and epifluorescence microscopy. Oxidation induced concentration- and time-dependent inhibition of surfactant adsorption and interfacial film stability. Langmuir balance experiments revealed selective disruption of films containing unsaturated phospholipids or native mixtures, while saturated monolayers remained largely unaffected. FTIR-ATR analysis showed perturbations in lipid headgroup regions and protein secondary structure rearrangements towards β-sheet-rich aggregates, consistent with oxidative unfolding and aggregation. These molecular changes compromise protein-lipid interactions, delaying adsorption and respreading at the air-liquid interface. Epifluorescence microscopy further revealed disruption of lateral lipid organization and altered formation of three-dimensional surfactant reservoirs enriched in disordered components. Functional assays confirmed impaired reduction of surface tension during quasi-static cycling, partially alleviated under dynamic cycling, suggesting exclusion or depuration of oxidized components from the interface. Together, these findings demonstrate that neutrophil-derived oxidants progressively compromise pulmonary surfactant by targeting lipid-protein cooperativity, leading to early interfacial dysfunction followed by structural reorganization. This mechanistic insight advances understanding of oxidative surfactant inactivation and supports the development of antioxidant strategies or oxidant-resistant surfactant formulations as potential therapeutic interventions for inflammatory lung injury.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pulmonary surfactant in asthma

  • Blanco, Odalys
  • Díaz Reyes, Mercyleidi
  • Labrada, Alexis
  • Autilio, Chiara
  • Pérez Gil, Jesús
Pulmonary surfactant is vital in human respiration. It maintains alveoli and terminal conducting airways open and therefore promotes an efficient gas exchange and low resistance in the airways during breathing dynamics. Lack or dysfunction of the pulmonary surfactant system is associated with severe lung disorders. Surfactant ability to maintain low surface tension at the respiratory air-liquid interface, with subsequent good compliance and low resistance in the airways, is extremely important for asthmatic patients. A growing series of experimental evidence indicates that surfactant dysfunction, either associated with the causes or as a consequence of asthma, can contribute to constriction of airways and exacerbation of asthma. Modulation by surfactant of the innate and induced immune response is also an important element defining propensity, but also the resolution of asthmatic crisis. Limited trials indicate that administration of exogenous therapeutic surfactant may offer favorable pharmacological effects to asthmatic patients, possibly by two different mechanisms. On the one hand, it can restore endogenous surface activity and, on the other hand, properly modulate the immune system. The objective of the present review has been to summarize and update available concepts and evidence that support the relationship between pulmonary surfactant and asthma, with particular attention to the role of pulmonary surfactant in the mechanisms of asthma manifestations as well as in the design of innovative future therapies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Escaping from Flatland: the role of proteins SP-B and SP-C in the formation of 3D structures in interfacial pulmonary surfactant films

  • Collada, Ainhoa
  • Carrascosa-Tejedor, Javier
  • Sanchez-Puga, Pablo
  • Liguori, Alessio
  • Gutfreund, Philipp
  • Santamaria, Andreas
  • Castillo-Sánchez, José Carlos
  • Maestro, Armando
  • Cruz, Antonio
  • Pérez-Gil, Jesús
Data will be made available on request., Deciphering the molecular structure of pulmonary surfactant (PS) at the respiratory air-liquid interface has remained a major challenge since its discovery. This is particularly critical at minimal lung volume and surface area at the end of exhalation, when PS rapidly reorganizes into a 3D membrane network without detaching from the interfacial film, ensuring readiness and stability for subsequent respiratory cycles. Using neutron reflectometry and epifluorescence microscopy in specially designed surface balances, we have investigated the structure of model PS membranes and films at different compression stages, focusing on the key roles of the hydrophobic surfactant proteins SP-B and SP-C in the organization of the system at the interface. The structure of the studied model surfactant films (both analysed orthogonal to the interfacial plane and laterally) strongly depended on composition. We clarified the distinct roles of SP-B and SP-C, revealing that only SP-B, the only protein in surfactant that is indispensable for life, nucleates 3D membrane reservoirs beneath the interface. These findings provide mechanistic insights into how PS maintains interfacial stability during respiration, with potential implications for understanding surfactant dysfunction in respiratory diseases and for designing biomimetic surfactant replacements., This work has been funded by grants from the Spanish Ministry of Science and Innovation (PID2021-124932OB-I00, PID2024-156556OB-I00). We thank the Institut Laue-Langevin for the allocations of neutron beam time (doi: 10.5291/ILL-DATA.8-02-865, doi: 10.5291/ILL-DATA.8-02-891, doi: 10.5291/ILL-DATA.8-02-990, doi: 10.5291/ILL-DATA.8-02-1004) and the Partnership for Soft Condensed Matter (PSCM) for lab support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel ultrastructural insights in lung surfactant membrane complexes under closer-to-native conditions as revealed by cryo-microscopy techniques

  • Chichón, Francisco Javier
  • Cerrada, Alejandro
  • Arranz, Rocío
  • Cruz, Antonio
  • Valpuesta, José M.
  • Pérez-Gil, Jesús
Lung surfactant (LS) plays an essential role in preventing lung collapse due to physical forces by forming surface-active lipid-protein membranous films at the respiratory air-liquid interface. Throughout its biological cycle, LS exists in a variety of metabolically related, conspicuous morphological forms. Epithelial alveolar type II cells store LS as intracellular, tightly packed, multilayered organelles known as lamellar bodies. These are secreted as still-condensed material in the form of lamellar body-like particles, which, upon adsorption, give rise to the interfacial film and surface-associated structures. Surfactant material purified from bronchoalveolar lavage fluids has been extensively examined by conventional transmission electron microscopy (TEM), providing important information about LS ultrastructure. However, potential artifacts associated with classical TEM preparation methods-such as staining, dehydration, resin embedding, and sectioning-hinder the observation of surfactant biological samples in their truly native state. In this work, we have taken advantage of cutting-edge cryo-microscopy techniques to visualize the structural complexity present in LS preparations without fixation, in a frozen-hydrated state, and thus closer to physiological conditions. The implementation of cryopreservation approaches has allowed us to unveil unprecedented ultrastructural details of the diverse morphological states in which LS is present in the alveolar spaces, such as the presence of a protein-based pore connecting the lumen of the lamellar body-like particles (LBPs) with the external milieu, and an onion-like structure that suggests a mechanism that uses the energy accumulated upon LB assembly in the pneumocytes for a rapid release of the membranous complexes to the exterior. These morphological features shed light on the dynamic processes by which LS is unpacked from secreted condensed states to the more disorganized, interconnected membranous networks that sustain breathing mechanics.NEW & NOTEWORTHY We have applied some of the most advanced methodologies in cryo-electron microscopy and X-ray tomography to the characterization of native pulmonary surfactant. We still do not understand the way lung surfactant membranes unravel, once secreted, at the respiratory air-liquid interface, and current models are still based on structural observations made when the methodologies available 30 years ago required extensive manipulation/perturbation of membrane materials. Our study reveals new features on the architecture of this system., This work was funded by the Spanish Ministry of Science and Innovation Grants PID2024-156556OB-I00 (to J.P.-G.), PID2022-137175NB-I00 (to AEI/FEDER, UE), (AEI/10.13039/501100011033) and the “Severo Ochoa” Programme for Centers of Excellence in R&D (CEX2023-001386-S) (to J.M.V. and J.C.). The support from the Caixa Research Health 2023 Grant HR23-00837 (to J.M.V.) is also acknowledged., Peer reviewed, Modelo experimental animal, Mamíferos - Otros mamíferos
Docta Complutense
Publicación Artículo científico (JournalArticle)

Thermodynamic Insights into Native Pulmonary Surfactant Films: Elastic Compression Modulus and Energy Dissipation under Cyclic Deformation

  • Riaño Rivera, Angela Johana
  • Rivera, Nataly Díaz
  • Alvarez Tinjacá, Angela Constanza
  • Leyva, J. Alfonso
  • Lopez-Rodriguez, Elena
  • Pérez Gil, Jesús
  • Ospina Ramírez, Olga Lucía
Native pulmonary surfactant (NPS) biophysical activity, reducing surface tension at the alveolar air–liquid interface and decreasing the work of breathing, is essential for life. Here we present an in vitro systematic characterization of the interfacial activity of porcine NPS films using a model air–liquid interface. For this purpose, standard surface balances were employed to measure adsorption kinetics, and the maximum surface pressure (minimal surface tension) was achieved at the end of isothermal compression. Cyclic compression and expansion of NPS films was performed under different experimental conditions, and both the surface compressive elastic modulus and the total work invested per cycle were estimated. A fourth-degree polynomial was fitted to the experimental data to obtain the compression and expansion trajectories, which were subsequently used to calculate the compressive elastic modulus at a specified pressure and, additionally, the hysteresis associated with each cycle. The compressive elastic modulus was measured before reaching the equilibrium pressure and remained essentially constant over all cycles, indicating the remarkable interfacial mechanical stability of the NPS films. The irreversibility of the thermodynamic cycles, manifested as hysteresis between compression and expansion isotherms, shows that the energy required is highest during the first cycle and decreases in subsequent cycles due to the exclusion of less stable molecular species from the air–liquid interface at high surface pressures. Taken together, the compressive elastic modulus and the hysteresis emerging from compression–expansion cycles can be considered as the functional performance metrics of pulmonary surfactant films. By focusing on the energetics and thermodynamics of compression–expansion breathing-like cycling, this approach complements traditional viscoelastic characterization and provides a functional framework to assess the stability and performance of pulmonary surfactant films.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Effect of hyaluronic acid on the performance of pulmonary surfactant. Towards the production of enhanced clinical surfactant formulations

  • Collada Marugán, Ainhoa
  • Blanco Rivero, Amaya
  • Cruz Rodríguez, Antonio
  • Pérez Gil, Jesús
In order to prevent alveolar collapse, the surface tension at the air-liquid interface of alveoli has to be minimized at the end of expiration. Pulmonary surfactant, a lipid-protein complex synthetized and secreted by type II pneumocytes, adsorbs into the alveolar surface to form highly surface-active interfacial films. Lack or inactivation of surfactant is associated with severe respiratory pathologies, some of them treated by supplementation with exogenous surfactant formulations. It has been demonstrated that surfactant is assembled by pneumocytes in a highly packed dehydrated state that unravels once secreted to exhibit optimal interfacial capacities. Once exposed to air and subjected to dynamic breathing, surfactant can be isolated from bronchoalveolar lavages (BAL) in more unpacked and relatively hydrated stages. In this work we have used different biophysical techniques, such as surface balances and fluorescence spectroscopy to show how BAL surfactant pre-exposed to certain polymers such as hyaluronic acid (HA) transits to a more stably packed state with improved functional capabilities that approach those of freshly secreted surfactant that had never been exposed to air, such as the surfactant that can be purified from amniotic fluid. These results open new opportunities to develop more efficient therapeutical surfactant preparations to treat respiratory pathologies still unresolved.